Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Sloan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Proceedings (Baylor University. Medical Center)|October 15, 2010
Central nervous system tuberculosisVincent C Kuo, Louis M Sloan, Michael Emmett
The Annals of Pharmacotherapy|May 29, 2020
Tropism Switching Is Rare in Aviremic HIV-Infected Patients Virologically Suppressed With Non-Entry-Inhibiting Antiretroviral RegimensLouis M Sloan, Mezgebe G Berhe, Anna Ursales, et al.
Proceedings (Baylor University. Medical Center)|January 27, 2009
Primary effusion lymphoma diagnosed by pericardiocentesisMichael C Nemunaitis, Jeffrey M Schussler, S Michelle Shiller, et al.
Proceedings (Baylor University. Medical Center)|July 2, 2014
Clinical and morphologic findings in disseminated Scedosporium apiospermum infections in immunocompromised patientsMolly M Campa-Thompson, James A West, Joseph M Guileyardo, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758Charles B Hicks, Edwin DeJesus, Louis M Sloan, et al.
AIDS Research and Human Retroviruses|October 9, 2012
Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIESBenjamin Young, Kathleen E Squires, Lisa L Ross, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Proceedings (Baylor University. Medical Center)|October 15, 2010
Central nervous system tuberculosisVincent C Kuo, Louis M Sloan, Michael Emmett
The Annals of Pharmacotherapy|May 29, 2020
Tropism Switching Is Rare in Aviremic HIV-Infected Patients Virologically Suppressed With Non-Entry-Inhibiting Antiretroviral RegimensLouis M Sloan, Mezgebe G Berhe, Anna Ursales, et al.
Proceedings (Baylor University. Medical Center)|January 27, 2009
Primary effusion lymphoma diagnosed by pericardiocentesisMichael C Nemunaitis, Jeffrey M Schussler, S Michelle Shiller, et al.
Proceedings (Baylor University. Medical Center)|July 2, 2014
Clinical and morphologic findings in disseminated Scedosporium apiospermum infections in immunocompromised patientsMolly M Campa-Thompson, James A West, Joseph M Guileyardo, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758Charles B Hicks, Edwin DeJesus, Louis M Sloan, et al.
AIDS Research and Human Retroviruses|October 9, 2012
Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIESBenjamin Young, Kathleen E Squires, Lisa L Ross, et al.
Pageof 1